CF vs ZYME · P/E 12, rev $5.94B vs rev $76.3M
CF Industries Holdings Inc (CF) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
CF currently screens at market cap $14.98B and trailing P/E 12.2. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the CF and ZYME stock pages for the full models.
Not investment advice.